MapLight Therapeutics logo

MapLight Therapeutics

MPLT | NASDAQ
Chart Builder DCF Calculator
$6.90
-$0.35 (-4.83%)
At close: Nov 16, 2026, 4:00 PM ET
$7.03
+$0.13 (+1.88%)
After-hours: Nov 16, 2026, 4:40 PM ET
-4.83%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
26.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #892/1021 (Top 87%)

Key Statistics

Market Data

Market Cap $313.48M
1D Range
6.88 7.48
52W Range
6.22 39.80

Valuation (TTM)

PE -1.33
PB 0.90
EV/EBITDA -0.05

Valuation (NTM)

Forward PE N/A
Forward PEG 0.05
Price Target $28.00
Loading financial charts...

Profile

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its p...

Sector Healthcare
Industry Biotechnology
Employees 133
IPO Date Oct 24, 2025
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$28.00
Upside
+305.80%
Buy (5)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.